Skip Navigation

Cardiovascular Research 1997 33(2):387-391; doi:10.1016/S0008-6363(96)00209-X
© 1997 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Boomsma, F.
Right arrow Articles by Schalekamp, M. A.D.H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boomsma, F.
Right arrow Articles by Schalekamp, M. A.D.H
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1997, European Society of Cardiology

Plasma semicarbazide-sensitive amine oxidase is elevated in patients with congestive heart failure

Frans Boomsmaa,*, Dirk J van Veldhuisenb, Pieter J de Kamb, Arie J Man in 't Velda, Arend Mosterdc, Kong I Lieb and Maarten A.D.H Schalekampa

aCardiovascular Research Institute COEUR, Division of Internal Medicine I, Room L-241, Erasmus University, Dr. Molewaterplein 40, 3015 GD Rotterdam, Netherlands
bDepartment of Cardiology/Thorax Center, University Hospital Groningen, Groningen, Netherlands
cDepartment of Epidemiology and Biostatistics, Erasmus University, Rotterdam, Netherlands

Objective: Semicarbazide-sensitive amine oxidase (SSAO) is present in various mammalian tissues, especially in vascular smooth muscle cells, but also in plasma. The enzyme has been suggested to play a role in vascular endothelial damage through conversion of amines into cytotoxic aldehydes, ammonia and hydrogen peroxide. Endothelial dysfunction is present in diabetes mellitus (DM) and congestive heart failure (CHF). Elevated plasma SSAO activities have been reported in patients with DM, but no data on patients with CHF are as yet available. Methods and Results: Plasma SSAO was measured in 271 patients with CHF and compared to values in 77 controls. SSAO was found to be elevated in patients with CHF compared to controls (589±252 vs. 455±114 mU/l; P<0.0001). Plasma SSAO was higher in NYHA class III/IV than in class III (662±288 vs. 555±226 mU/l; P=0.004) and also higher in patients with concomitant DM than in those without (706±248 vs. 557±245 mU/l; P<0.0001). Plasma SSAO correlated with plasma atrial natriuretic peptide (r=0.42; P<0.0001), with plasma norepinephrine (r=0.27; P<0.0001) and with left ventricular ejection fraction (r=–0.13; P=0.0162). Multiple regression analysis showed atrial natriuretic peptide, norepinephrine, DM and cardiothoracic ratio to be the main determinants of plasma SSAO. Conclusion: The finding of elevated plasma SSAO in CHF, increasing with severity of the disease and with the concomitant presence of DM, supports the suggestion that SSAO may be involved in the pathogenesis of vascular endothelial damage. Plasma SSAO may be a useful parameter in assessing severity of CHF and in prognostic evaluation. Pharmacologic manipulation of SSAO activity might be an interesting new concept for prevention of vascular endothelial damage in various vascular disease entities.

KEYWORDS Heart failure; Diabetes; Neurohormones; Human; Semicarbazide-sensitive amino oxidase

* Corresponding author. Tel. +31 10 4633764; Fax +31 10 4634531.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J BiochemHome page
M. Hernandez-Guillamon, I. Bolea, M. Sole, M. Boada, K.F. Tipton, and M. Unzeta
Sodium Bicarbonate Enhances Membrane-bound and Soluble Human Semicarbazide-sensitive Amine Oxidase Activity In Vitro
J. Biochem., November 1, 2007; 142(5): 571 - 576.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. Kazachkov, K. Chen, S. Babiy, and P. H. Yu
Evidence for in Vivo Scavenging by Aminoguanidine of Formaldehyde Produced via Semicarbazide-Sensitive Amine Oxidase-Mediated Deamination
J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1201 - 1207.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
N. Mercier, K. El Hadri, M. Osborne-Pellegrin, J. Nehme, C. Perret, C. Labat, V. Regnault, J.-M. D. Lamaziere, P. Challande, P. Lacolley, et al.
Modifications of Arterial Phenotype in Response to Amine Oxidase Inhibition by Semicarbazide
Hypertension, July 1, 2007; 50(1): 234 - 241.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
N. Mercier, M. Osborne-Pellegrin, K. El Hadri, A. Kakou, C. Labat, L. Loufrani, D. Henrion, P. Challande, S. Jalkanen, B. Feve, et al.
Carotid arterial stiffness, elastic fibre network and vasoreactivity in semicarbazide-sensitive amine-oxidase null mouse
Cardiovasc Res, November 1, 2006; 72(2): 349 - 357.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
P. H. Yu, L.-X. Lu, H. Fan, M. Kazachkov, Z.-J. Jiang, S. Jalkanen, and C. Stolen
Involvement of Semicarbazide-Sensitive Amine Oxidase-Mediated Deamination in Lipopolysaccharide-Induced Pulmonary Inflammation
Am. J. Pathol., March 1, 2006; 168(3): 718 - 726.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
D. Gubisne-Haberle, W. Hill, M. Kazachkov, J. S. Richardson, and P. H. Yu
Protein Cross-Linkage Induced by Formaldehyde Derived from Semicarbazide-Sensitive Amine Oxidase-Mediated Deamination of Methylamine
J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 1125 - 1132.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
C. M. Stolen, G. G. Yegutkin, R. Kurkijarvi, P. Bono, K. Alitalo, and S. Jalkanen
Origins of Serum Semicarbazide-Sensitive Amine Oxidase
Circ. Res., July 9, 2004; 95(1): 50 - 57.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
P. H. Yu, M. Wang, H. Fan, Y. Deng, and D. Gubisne-Haberle
Involvement of SSAO-mediated deamination in adipose glucose transport and weight gain in obese diabetic KKAy mice
Am J Physiol Endocrinol Metab, April 1, 2004; 286(4): E634 - E641.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
C. Gokturk, J. Nilsson, J. Nordquist, M. Kristensson, K. Svensson, C. Soderberg, M. Israelson, H. Garpenstrand, M. Sjoquist, L. Oreland, et al.
Overexpression of Semicarbazide-Sensitive Amine Oxidase in Smooth Muscle Cells Leads to an Abnormal Structure of the Aortic Elastic Laminas
Am. J. Pathol., November 1, 2003; 163(5): 1921 - 1928.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. F. Lalor, S. Edwards, G. McNab, M. Salmi, S. Jalkanen, and D. H. Adams
Vascular Adhesion Protein-1 Mediates Adhesion and Transmigration of Lymphocytes on Human Hepatic Endothelial Cells
J. Immunol., July 15, 2002; 169(2): 983 - 992.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
M. Exner, M. Hermann, R. Hofbauer, S. Kapiotis, P. Quehenberger, W. Speiser, I. Held, and B. M.K Gmeiner
Semicarbazide-sensitive amine oxidase catalyzes endothelial cell-mediated low density lipoprotein oxidation
Cardiovasc Res, June 1, 2001; 50(3): 583 - 588.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
P.H. Yu
Semicarbazide-sensitive amine oxidase and mortality in chronic heart failure
Eur. Heart J., November 2, 2000; 21(22): 1812 - 1814.
[PDF]

Home page
 Eur Heart JHome page
F Boomsma, P.J de Kam, G Tjeerdsma, A.H van Den Meiracker, and D.J van Veldhuisen
Plasma semicarbazide-sensitive amine oxidase (SSAO) is an independent prognostic marker for mortality in chronic heart failure
Eur. Heart J., November 2, 2000; 21(22): 1859 - 1863.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.